Cargando…

Comparison of four serum tumour markers in the diagnosis of colorectal carcinoma.

The assessment of the diagnostic power of four serum tumour markers, CEA, CA 19-9, CA 50 and CA 195 for colorectal carcinoma is described, according to recently formulated guidelines. Preoperative serum concentrations of the four markers were determined in 198 colorectal cancer patients and 57 patie...

Descripción completa

Detalles Bibliográficos
Autores principales:	van der Schouw, Y. T., Verbeek, A. L., Wobbes, T., Segers, M. F., Thomas, C. M.
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 1992
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1977887/ https://www.ncbi.nlm.nih.gov/pubmed/1379057

Ejemplares similares

The phase of the menstrual cycle has no influence on the disease-free survival of patients with mammary carcinoma.
por: Wobbes, T., et al.
Publicado: (1994)

Comparison of carcinoembryonic antigen prognostic value in serum and tumour tissue of patients with colorectal cancer
por: Li, M, et al.
Publicado: (2009)

Serum tumour markers in carcinoma of the uterine cervix and outcome following radiotherapy.
por: Sproston, A. R., et al.
Publicado: (1995)

The association of preoperative serum tumour markers with Dukes' stage and survival in colorectal cancer.
por: Lindmark, G., et al.
Publicado: (1995)

Frequency of serum tumour marker monitoring.
por: Colls, B. M.
Publicado: (1991)

Clinical evaluation of serum alpha-fetoprotein and circulating immune complexes as tumour markers of hepatocellular carcinoma.
por: Tsai, J. F., et al.
Publicado: (1995)

Serum anti-p53 antibody as a tumour marker for colorectal cancer screening
por: Iwamuro, Masaya, et al.
Publicado: (2015)

Tumour markers of prognosis in colorectal cancer
por: McLeod, H L, et al.
Publicado: (1999)

Serum proteins as tumour markers for breast cancer.
por: Mattison, P., et al.
Publicado: (1981)

Clinical evaluation of a new serum tumour marker CA 242 in pancreatic carcinoma.
por: Pasanen, P. A., et al.
Publicado: (1992)

Clinical value evaluation of serum markers for early diagnosis of colorectal cancer
por: Song, Wen-Yue, et al.
Publicado: (2020)

Clinical evaluation of urinary transforming growth factor-beta1 and serum alpha-fetoprotein as tumour markers of hepatocellular carcinoma.
por: Tsai, J. F., et al.
Publicado: (1997)

Serum Tumor Markers for Early Diagnosis of Primary Hepatocellular Carcinoma
por: Zong, Jingjing, et al.
Publicado: (2020)

Clinical outcome of hepatocellular carcinoma can be predicted by the expression of hepatic progenitor cell markers and serum tumour markers
por: Seino, Satoshi, et al.
Publicado: (2018)

Frequency of serum tumour marker monitoring in patients with non-seminomatous germ cell tumours.
por: Seckl, M. J., et al.
Publicado: (1990)

International scientific communications in the field of colorectal tumour markers
por: Ivanov, Krasimir, et al.
Publicado: (2017)

Faecal tumour pyruvate kinase M2: not a good marker for the detection of colorectal adenomas
por: Shastri, Y M, et al.
Publicado: (2008)

Tissue levels of active matrix metalloproteinase-2 and -9 in colorectal cancer
por: Waas, E T, et al.
Publicado: (2002)

Magnetic resonance imaging in size assessment of invasive breast carcinoma with an extensive intraductal component
por: Schouten van der Velden, Arjan P, et al.
Publicado: (2009)

Neuron-specific enolase--a serum tumour marker in seminoma?
por: Fosså, S. D., et al.
Publicado: (1992)

Serum Metallothioneins in Childhood Tumours—A Potential Prognostic Marker
por: Kruseova, Jarmila, et al.
Publicado: (2013)

Evaluation of seven tumour markers in pleural fluid for the diagnosis of malignant effusions
por: Miédougé, M, et al.
Publicado: (1999)

Serum Markers in the Diagnosis of Tubal Pregnancy
por: Cabar, Fabio Roberto, et al.
Publicado: (2008)

Disruption of the circadian patterns of serum cortisol in breast and ovarian cancer patients: relationships with tumour marker antigens.
por: Touitou, Y., et al.
Publicado: (1996)

Evaluation of CA 19-9 as a serum tumour marker in pancreatic cancer.
por: Haglund, C., et al.
Publicado: (1986)

Tumor bacterial markers diagnose the initiation and four stages of colorectal cancer
por: Cai, Ping, et al.
Publicado: (2023)

Change in incidence, characteristics and management of colorectal neuroendocrine tumours in the Netherlands in the last decade
por: Kooyker, Arthur I, et al.
Publicado: (2019)

Clinical significance of circulating tumour cells and tumour marker detection in the chemotherapeutic evaluation of advanced colorectal cancer
por: Shen, Feifei, et al.
Publicado: (2021)

Comparison of seven serum assays on four automatic analysers
por: Sacchetti, Lucia, et al.
Publicado: (1989)

Brain metastases in malignant teratoma: a review of four years' experience and an assessment of the role of tumour markers.
por: Kaye, S. B., et al.
Publicado: (1979)

Epidermal growth factor receptor levels are lower in carcinomatous than in normal colorectal tissue.
por: Koenders, P. G., et al.
Publicado: (1992)

Direct comparison of five serum biomarkers in early diagnosis of hepatocellular carcinoma
por: Chen, Hongda, et al.
Publicado: (2018)

Carbohydrate antigen 19-9 as a serum marker of hepatocellular carcinoma: comparison with alpha-foetoprotein.
por: Kew, M. C., et al.
Publicado: (1987)

Serum thyroglobulin as a preclinical tumour marker in subgroups of thyroid cancer.
por: Thoresen, S. O., et al.
Publicado: (1988)

A serum factor with potential as a tumour marker in malignant lymphoma.
por: Begent, R. H., et al.
Publicado: (1980)

Cellular fibronectin in serum and plasma: a potential new tumour marker?
por: Ylätupa, S., et al.
Publicado: (1995)

Serum inflammatory markers and colorectal cancer risk and survival
por: Ghuman, Sundeep, et al.
Publicado: (2017)

The Association of Baseline Serum Tumour Markers with Outcome of Patients with Metastatic Colorectal Cancer Treated with Anti-EGFR Monoclonal Antibodies in the First Line
por: Fiala, Ondrej, et al.
Publicado: (2018)

The value of haematological parameters and serum tumour markers for predicting KRAS mutations in 784 Chinese colorectal cancer patients: a retrospective analysis
por: Cao, Yinghao, et al.
Publicado: (2020)

Synchronous polypectomy during endoscopic diagnosis of colorectal cancer – is the risk of tumour implantation at the polypectomy site significant?
por: Tan, W. J., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_i5s8cueionekc5md8v4kt8g7dj